Immunophenotype of myeloid cells in myelodysplastic syndromes and its clinical implications

Chinese Medical Journal

Volumn 111, Issue 1, 1998, Pages 28-31

  Shao, Zonghong ^a   Chen, Guibin ^a   Lin, Zexi ^a   Zhang, Yizhi ^a   Hao, Yushu ^a   Chu, Yulin ^a   Zheng, Yizhou ^a   Qian, Linsheng ^a   Yang, Tianying ^a   Yang, Chongli ^a   Feng, Baozhang ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD33 ANTIGEN; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; MICROSOMAL AMINOPEPTIDASE;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW CELL; FEMALE; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROME; PATHOLOGY; PROGNOSIS;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD13; ANTIGENS, CD14; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BONE MARROW CELLS; FEMALE; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROGNOSIS;

EID: 0031598669     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Shao ZH, Hao YS. Progresses of study on the immumophem-type of myeloid cells from MDS patients. Foreig Med Sci Semin Transfus Haematol 1994; 17:238.
2. Clark RE, Hoy TG, Jacobs A. Granuloeyte and monocyte surface membrane markers in the myelodysplastic syndromes. J Clin Pathol 1985; 38:301.
3. Hokland P, Kemdrup G, Griffin JD, et al. Analysis of leukocyte differentiation antigens in blood and bone marrow from preleukemia (reflation anemia) patients using monoclonal antibodies. Blood 1986; 67:898.
4. Clark RE, Smith SA, Jacobs A. Myeloid surface antigen abnormalities in myelodysplasis: relation to prognosis and modification by 13-cis retinoic acid. J Clin Pathol 1987; 40:652.
5. Kemdrup G, Bendix-Hangen K, Pedersen B, et al. Analysis of leucocyte differentiation antigens in blood and bone marrow in patients with refractory anemia (RA) and RA with sideroblasts. Prognostic implications of sequential and follow-up date. Eur J Haematol 1988; 41:368.
6. Kristensen JS, Hokland P. Monoclonal antibody ratios in malignant imeloid diseases: diagnostic and prognostic use in myelodysplastic syndromes. Br J Haematol 1990; 74:270.
7. Woodlock TJ, Seshi B. Sham R, et al. Use of cell surface antigen phenotype in guiding therapeutic decisions in chronic myelomonocyte leukemia. Leuk Res 1994; 18:173.